000 01762 a2200553 4500
005 20250516190437.0
264 0 _c20140806
008 201408s 0 0 eng d
022 _a1939-327X
024 7 _a10.2337/db13-1042
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZuellig, Richard A
245 0 0 _aDeoxysphingolipids, novel biomarkers for type 2 diabetes, are cytotoxic for insulin-producing cells.
_h[electronic resource]
260 _bDiabetes
_cApr 2014
300 _a1326-39 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBiomarkers
650 0 4 _aBlood Glucose
_xmetabolism
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aCellular Senescence
_xdrug effects
650 0 4 _aCytoskeleton
_xdrug effects
650 0 4 _aHumans
650 0 4 _aInsulin-Secreting Cells
_xdrug effects
650 0 4 _aIslets of Langerhans
_xdrug effects
650 0 4 _aLipids
650 0 4 _aMice
650 0 4 _aRats
650 0 4 _aSignal Transduction
650 0 4 _aSphingosine
_xanalogs & derivatives
700 1 _aHornemann, Thorsten
700 1 _aOthman, Alaa
700 1 _aHehl, Adrian B
700 1 _aBode, Heiko
700 1 _aGüntert, Tanja
700 1 _aOgunshola, Omolara O
700 1 _aSaponara, Enrica
700 1 _aGrabliauskaite, Kamile
700 1 _aJang, Jae-Hwi
700 1 _aUngethuem, Udo
700 1 _aWei, Yu
700 1 _avon Eckardstein, Arnold
700 1 _aGraf, Rolf
700 1 _aSonda, Sabrina
773 0 _tDiabetes
_gvol. 63
_gno. 4
_gp. 1326-39
856 4 0 _uhttps://doi.org/10.2337/db13-1042
_zAvailable from publisher's website
999 _c23406372
_d23406372